Soo Ki Kim

10PUBLICATIONS
76CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Metabolic medicineCancer diagnosisBiomechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 20, 2026
Baseline DCP May Modify Response to Atezolizumab-Bevacizumab Versus Durvalumab-Tremelimumab in Unresectable HCC.

|Jul 16, 2026
Simplified BALAD (BALAD-S) Score as a Guide for First-Line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma.

|Apr 21, 2026
Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

|Feb 27, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease and Sarcopenia: Review of Literature.

Hiroki Nishikawa, Soo Ki Kim, Sachiyo Yoshio

|Jan 10, 2026
Primary Hepatic Squamous Cell Carcinoma.

Soo Ryang Kim, Soo Ki Kim, Hisato Kobayashi

|Jul 12, 2025
Factors Associated with Changes in Skeletal Muscle Mass in Medical Health Checkups.

Saori Onishi, Akira Fukuda, Masahiro Matsui

Pageof 2

Frequent Collaborators

6 joint publications

Akira Asai

5 joint publications

Hiroki Nishikawa

3 joint publications

Toshifumi Tada

3 joint publications

Atsushi Hiraoka